25.03.2022 CompuGroup Medical SE & Co. KGaA  DE000A288904

DGAP-News: CompuGroup Medical to acquire Insight Health as significant step forward in data business


 

DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Mergers & Acquisitions
CompuGroup Medical to acquire Insight Health as significant step forward in data business

25.03.2022 / 16:01
The issuer is solely responsible for the content of this announcement.


Koblenz/Waldems-Esch: CompuGroup Medical SE & Co KGaA (CGM), one of the world's leading e-health companies, announces the acquisition of Insight Health Group, a leading health care data services specialist. The acquisition strengthens CGM's position in the area of innovative data solutions.

Insight Health, founded in 1999, offers innovative solutions for market and health care research in the German health care sector while applying the highest level of data protection. Its clients include well-known companies in the pharmaceutical industry, pharmacies, doctors' associations, health insurance companies as well as scientific and political institutions.

The products and services developed by Insight Health enable individual and customer-specific market analyses based on extensive data sources. These are fed by the full survey of all statutory health insurance prescriptions via pharmacy data centers, the full survey of pharmaceutical wholesalers and a pharmacy panel of 5,800 continuously contributing pharmacies. In addition, it is possible to obtain precise information on the quantities and regional distribution of prescriptions. From this, customers gain insights based on aggregated data on medication, prescriptions and billing according to regional differentiation, which provides them with a data-based foundation for strategic decisions in the health care sector.

CGM expands data-based solutions offering

With the planned acquisition of Insight Health, CGM is accelerating its business in data-driven solutions, which is already one of the company's fastest growing businesses. CGM already offers a broad portfolio of products in the data sector. These include contraindication checks, information on medication, business intelligence tools and solutions to detect rare diseases using aggregated data and Artificial Intelligence.

The planned integration of Insight Health strengthens CGM's position in the German health care market in data-driven information delivery, enabling real-time insights along the entire cycle from diagnosis via prescription to medication delivery.

"The integration of Insight Health is another decisive step by CGM on its way to becoming one of the leading European health care data service providers", commented Dirk Wössner, CEO CompuGroup Medical, on the planned acquisition. "Insight Health's strategy and strong growth market in the area of health care market data analysis and provision are an excellent fit with CGM's strategy."

With Insight Health CGM complements its solution portfolio with market and care data, increasing transparency in the health care market for physicians and patients as well as the entire industry, enabling informed decisions and optimizing day-to-day work.

"I am very pleased that we were able to win CompuGroup Medical, a very experienced investor in the health care market, with whom we will jointly drive further national and international expansion and continue on our growth path with new, innovative solutions for our customers and partners", says Michael Hensoldt, Chairman of the Management Board of Insight Health.

"Smart data solutions provide better access to relevant medical information for doctors and patients when they really need it", emphasizes Dr. Eckart Pech, Managing Director Consumer and Health Management Information Systems, CompuGroup Medical. "They are also a catalyst for increasing efficiency in health care. The integration of Insight Health is a key building block in CGM's evolution into a major data player."

Highest standards for data protection

As companies operating in the health care industry, CGM and Insight Health share the same standards for data privacy and security. The accompanying ethical responsibility and the commitment to all providing and using institutions is firmly embedded in the DNA of both companies.

Antitrust approval is still pending and the transaction is expected to close during the next months.

About CompuGroup Medical SE & Co. KGaA

CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 1.025 billion in 2021, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the health care system and its web-based personal health records contribute towards safer and more efficient health care. CompuGroup Medical's services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists, and other health care professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among health care professionals. More than 8,500 highly qualified employees support customers with innovative solutions for the steadily growing demands of the health care system.

Contact for Media Representatives:
Alexander Weimer
Head of Corporate Communication
P +49 (0) 261 8000-6100
M [email protected]

Contact for Analysts and Investors:
Claudia Thomé
Corporate Vice President Investor Relations
P +49 (0) 160 3630362
M [email protected]



25.03.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)261 8000 7030
Fax: +49 (0)261 8000 3200
E-mail: [email protected]
Internet: www.cgm.com
ISIN: DE000A288904
WKN: A28890
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1312293

 
End of News DGAP News Service

1312293  25.03.2022 

fncls.ssp?fn=show_t_gif&application_id=1312293&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 582,38 717,02 745,81 837,26 1.025,32 1.129,74 1.187,66
EBITDA1,2 128,44 187,84 178,13 197,48 213,39 216,35 229,76
EBITDA-Marge3 22,05 26,20 23,88 23,59 20,81 19,15
EBIT1,4 90,07 143,23 115,27 121,77 102,68 104,03 113,96
EBIT-Marge5 15,47 19,98 15,46 14,54 10,01 9,21 9,60
Jahresüberschuss1 31,74 96,34 66,15 73,42 69,03 74,12 46,87
Netto-Marge6 5,45 13,44 8,87 8,77 6,73 6,56 3,95
Cashflow1,7 85,82 136,35 110,50 149,93 165,27 145,03 179,53
Ergebnis je Aktie8 0,63 1,92 1,33 1,40 1,30 1,40 0,88
Dividende8 0,35 0,50 0,50 0,50 0,50 0,50 0,35
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: KPMG

INVESTOR-INFORMATIONEN
©boersengefluester.de
CompuGroup Medical
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A28890 29,080 Halten 1.562,60
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
22,37 35,84 0,63 24,96
KBV KCV KUV EV/EBITDA
2,54 8,70 1,32 9,76
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,50 1,00 3,44 22.05.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
08.05.2024 08.08.2024 07.11.2024 28.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-5,92% -20,62% -23,27% -41,70%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu CompuGroup Medical SE & Co. KGaA  ISIN: DE000A288904 können Sie bei EQS abrufen


Software , A28890 , COP , XETR:COP